Abbott Financial Statements From 2010 to 2026

Stocks . Germany . 
Stock . Abbott Laboratories
ABL Stock   91.49  0.68  0.74%   
Analyzing historical trends in various income statement and balance sheet accounts from Abbott Laboratories' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Abbott Laboratories' valuation are summarized below:
Market Capitalization
210.4 B
Enterprise Value Revenue
4.3941
There are currently sixty-three fundamental signals for Abbott Laboratories that can be evaluated and compared over time across rivals. All traders should validate Abbott Laboratories' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Abbott Laboratories Total Revenue

38.39 Billion

Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Interest Income of 415.4 M, Interest Expense of 529.1 M or Selling General Administrative of 11 B, as well as many indicators such as . Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
  
This module can also supplement various Abbott Laboratories Technical models . Check out the analysis of Abbott Laboratories Correlation against competitors.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Laboratories Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets78.3 B93.6 B66.4 B
Slightly volatile
Other Current Liabilities196 M220.5 M240.7 M
Slightly volatile
Total Current Liabilities12.7 B16.3 B10.2 B
Slightly volatile
Total Stockholder Equity37.2 B54.8 B30.6 B
Slightly volatile
Retained Earnings34.1 B54.4 B30.6 B
Slightly volatile
Accounts Payable3.8 B4.8 B2.8 B
Slightly volatile
Cash6.8 B6.9 B11.9 B
Slightly volatile
Non Current Assets Total54.7 B66.4 B42.6 B
Slightly volatile
Non Currrent Assets Other11.5 B18.9 B8.3 B
Slightly volatile
Long Term Debt14.3 B11.4 B18.2 B
Slightly volatile
Net Receivables6.3 B8 B5 B
Slightly volatile
Good Will23.8 B26.6 B17.1 B
Slightly volatile
Short Term Investments325.4 M403.6 M254.2 M
Slightly volatile
Non Current Liabilities Total20.5 B17.4 B24.7 B
Slightly volatile
Inventory5.3 B7.1 B4.1 B
Slightly volatile
Total Liabilities29.7 B30.2 B34.5 B
Pretty Stable
Long Term Investments862 M797.4 M1.7 B
Slightly volatile
Short and Long Term Debt1.2 B1.7 B1.2 B
Very volatile
Total Current Assets23.6 B27.2 B23.8 B
Slightly volatile
Non Current Liabilities Other2.7 B2.1 B2.8 B
Slightly volatile
Short Term Debt744.8 M1.3 B1.2 B
Very volatile
Intangible Assets10.3 B6 B9.3 B
Slightly volatile
Net Debt9 B5.9 B13.8 B
Slightly volatile
Common Stock Shares Outstanding1.4 B1.6 B1.7 B
Slightly volatile
Net Invested Capital59.4 B71.1 B57.3 B
Very volatile
Net Working Capital9.5 B10.9 B9.9 B
Slightly volatile
Capital Stock26.8 B28.9 B24.4 B
Slightly volatile
Property Plant And Equipment Net10.3 B12.3 B8.9 B
Slightly volatile
Capital Lease Obligations990.2 M1 B836.3 M
Slightly volatile
Property Plant And Equipment Gross22 B26.2 B18.8 B
Slightly volatile

Abbott Laboratories Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income415.4 M395.6 M166.4 M
Slightly volatile
Selling General Administrative11 B13.5 B9.1 B
Slightly volatile
Total Revenue38.4 B48.2 B30.9 B
Slightly volatile
Gross Profit21.7 B26.7 B17.5 B
Slightly volatile
Operating Income5.9 B7.8 B4.8 B
Slightly volatile
Net Income From Continuing Ops16.2 B15.4 B4.9 B
Slightly volatile
EBIT7.2 B10.2 B6.2 B
Slightly volatile
Research Development2.7 B3.3 B2.1 B
Slightly volatile
Cost Of Revenue16.7 B21.5 B13.5 B
Slightly volatile
Total Operating Expenses32.5 B40.4 B26.1 B
Slightly volatile
Income Before Tax5.6 B8.1 B4 B
Slightly volatile
Net Income16.2 B15.4 B5 B
Slightly volatile
EBITDA9.2 B12.3 B8 B
Slightly volatile
Reconciled Depreciation3.6 B3.7 B3.2 B
Slightly volatile

Abbott Laboratories Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation3.3 B3.7 B2.5 B
Slightly volatile
Capital Expenditures1.9 B2.5 B1.6 B
Slightly volatile
Total Cash From Operating Activities7.9 B9.8 B6 B
Slightly volatile
Net Income16.2 B15.4 B5 B
Slightly volatile
End Period Cash Flow6.8 B6.9 B11.9 B
Slightly volatile
Free Cash Flow6.5 B7.3 B5.4 B
Slightly volatile
Begin Period Cash Flow6.9 B6.2 B12.5 B
Slightly volatile
Other Non Cash Items27.4 M28.8 M445.7 M
Slightly volatile
Stock Based Compensation679.6 M774 M578.3 M
Slightly volatile

Abbott Fundamental Market Drivers

About Abbott Laboratories Financial Statements

Abbott Laboratories shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue48.2 B38.4 B
Cost Of Revenue21.5 B16.7 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY